Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Targeting Vδ1+T-cells may help treat alopecia areata.

Different immune cells like platelets, mast cells, neutrophils, macrophages, T cells, B cells, and innate lymphoid cells all play roles in skin wound healing, but more research is needed due to inconsistent results and the complex nature of the immune response.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Children with alopecia areata have immune imbalances and are more likely to have certain health issues.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Thyroid-related genes are active in skin cells and may affect autoimmune conditions.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

The skin and thymus develop similarly to protect and support immunity.

Inflammation linked to the immune response may play a role in causing various types of hair loss.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Hydrogel scaffolds can help wounds heal better and grow hair.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Human body's immune cells are more common in the layer of fat just beneath the skin than in deeper fat layers.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

Mast cell and nerve fiber interactions in mouse skin change with the hair cycle.

Stress can worsen skin conditions by affecting immune responses and skin cell activities.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

CD4 is crucial for maintaining skin stem cell balance and aiding wound healing.

Apremilast may help treat hair loss in alopecia areata.

Alarmin cytokines are key in controlling skin immunity and inflammation.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.